Arax Advisory Partners’s Nuvalent NUVL Stock Holding History

Arax Advisory Partners’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,076	Closed	-$93.1K	–	4397
2025 Q3	$93.1K	Buy	+1,076	New	+$85.1K	﹤0.01%	1563

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arax Advisory Partners's NUVL Position: Q4 2025 in Review

Arax Advisory Partners sold out of Nuvalent (NUVL) in Q4 2025, closing a stake of 1,076 shares — an estimated $93.1K sold.

Arax Advisory Partners first reported a position in NUVL in Q3 2025 and held it in 1 quarter. The position peaked at $93.1K in Q3 2025. 237 funds tracked by Wall St. Rank hold NUVL as of Q4 2025.

Arax Advisory Partners reported no remaining Nuvalent position as of Q4 2025 after selling out during the quarter.
Arax Advisory Partners sold 1,076 Nuvalent shares in Q4 2025, an estimated $93.1K.
Arax Advisory Partners first reported a position in Nuvalent in Q3 2025 and held it in 1 quarter.
Arax Advisory Partners's Nuvalent position peaked at $93.1K in Q3 2025.
237 funds tracked by Wall St. Rank held Nuvalent as of Q4 2025.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.